I worked towards having a sizeable ticket in the outcome of this...

I worked towards having a sizeable ticket in the outcome of this first trial, and in all the other
upcoming company developments.

Just like many others, I've been here too long to not have a material stake in any upside.
I've asked myself many times whether the upside potential commensurate with the downside
risks. At this stage of the trial, no negative side effects to participants have been reported and
perhaps finally further enrolment has been achieved as the number of participants cannot
remain at just five considering any concerns prospective participants may have had
regarding the 'safety' of this trial have been mitigated.

For me, IBX deserves to remain in my portfolio, but, as investors, we all have our own objective
questions that we ponder over as they help us make less superficial judgments...of which I may
still be entirely wrong. The company (in its last quarterly) demonstrated to have sufficient funds
to readily provide company running costs (plus cover any contingencies that may occur) to comfortably
see them through to the end of this trial. Who knows when we will need to raise more, but on paper,
there is no need to raise funds at this time.

No one really knows what will transpire but I feel that the glass half emptiers (without substantiation)
will be the ones left disappointed.

All just my opinion.